Furthermore, the use of NfL has not been limited to A-ATTR amyloidosis, but also to other amyloidoses such as AL10 and other neurological diseases such as multiple sclerosis, Charcot-Marie-Tooth, chronic inflammatory demyelinating polyneuropathy or Alzheimer's disease11–13. This evidence concerns the gene NEFL and amyloidosis.